These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 18398615

  • 1. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D, Mondick JT, Jayaraman B, Thompson PA, Blaney SM, Bernstein M, Bond M, Champagne M, Fossler MJ, Barrett JS.
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics and pharmacogenetics of imatinib in children and adults.
    Petain A, Kattygnarath D, Azard J, Chatelut E, Delbaldo C, Geoerger B, Barrois M, Séronie-Vivien S, LeCesne A, Vassal G, Innovative Therapies with Children with Cancer European consortium.
    Clin Cancer Res; 2008 Nov 01; 14(21):7102-9. PubMed ID: 18981009
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic-pharmacodynamic relationships of imatinib and its main metabolite in patients with advanced gastrointestinal stromal tumors.
    Delbaldo C, Chatelut E, Ré M, Deroussent A, Séronie-Vivien S, Jambu A, Berthaud P, Le Cesne A, Blay JY, Vassal G.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6073-8. PubMed ID: 17062683
    [Abstract] [Full Text] [Related]

  • 4. Use of total and unbound imatinib and metabolite LC-MS/MS assay to understand individual responses in CML and GIST patients.
    Streit F, Binder L, Hafke A, Brandhorst G, Braulke F, Haase D, Armbrust T, Cameron S, Ramadori G, Oellerich M, Walson P.
    Ther Drug Monit; 2011 Oct 15; 33(5):632-43. PubMed ID: 21912334
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
    Cohen MH, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, Benson K, Leighton J, Kim SK, Wood R, Rothmann M, Chen G, U KM, Staten AM, Pazdur R.
    Clin Cancer Res; 2002 May 15; 8(5):935-42. PubMed ID: 12006504
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients.
    Peng B, Hayes M, Resta D, Racine-Poon A, Druker BJ, Talpaz M, Sawyers CL, Rosamilia M, Ford J, Lloyd P, Capdeville R.
    J Clin Oncol; 2004 Mar 01; 22(5):935-42. PubMed ID: 14990650
    [Abstract] [Full Text] [Related]

  • 14. Metabolism and disposition of imatinib mesylate in healthy volunteers.
    Gschwind HP, Pfaar U, Waldmeier F, Zollinger M, Sayer C, Zbinden P, Hayes M, Pokorny R, Seiberling M, Ben-Am M, Peng B, Gross G.
    Drug Metab Dispos; 2005 Oct 01; 33(10):1503-12. PubMed ID: 16006570
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevations of creatine kinase in patients treated with imatinib mesylate (Gleevec).
    Gordon JK, Magid SK, Maki RG, Fleisher M, Berman E.
    Leuk Res; 2010 Jun 01; 34(6):827-9. PubMed ID: 19963273
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.
    Pappas P, Karavasilis V, Briasoulis E, Pavlidis N, Marselos M.
    Cancer Chemother Pharmacol; 2005 Oct 01; 56(4):358-60. PubMed ID: 15883819
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia.
    Boddy AV, Sludden J, Griffin MJ, Garner C, Kendrick J, Mistry P, Dutreix C, Newell DR, O'Brien SG.
    Clin Cancer Res; 2007 Jul 15; 13(14):4164-9. PubMed ID: 17634544
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.